CVRx (CVRX) EBT Growth (1y) (2021 - 2026)
Powered by 
Analysis
CVRx (CVRX) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -29.12% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 26.74% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 35.87% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 53.94% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 12.65% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.89% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -123.12% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 31.69% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 17.94% |
| 10 | CVRx | 75.57 Mn | 10.98 Mn | 13.72 Mn | 4.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.74% |
| Mar 31, 2026 | 4.73% |
| Dec 31, 2025 | -11.24% |
| Sep 30, 2025 | 1.37% |
| Jun 30, 2025 | -5.37% |
| Mar 31, 2025 | 37.82% |
| Dec 31, 2024 | -17.65% |
| Sep 30, 2024 | -45.49% |
| Jun 30, 2024 | -20.41% |
| Mar 31, 2024 | -95.31% |
| Dec 31, 2023 | 13.17% |
| Sep 30, 2023 | 8.44% |
| Jun 30, 2023 | -5.15% |
| Mar 31, 2023 | -13.80% |
| Dec 31, 2022 | 0.35% |
| Sep 30, 2022 | -60.36% |
| Jun 30, 2022 | 37.66% |
| Mar 31, 2022 | -15.74% |
| Dec 31, 2021 | -211.89% |
| Sep 30, 2021 | -90.46% |